Businesses funded 88% of domestic corporate research and development spending in 2023, increasing their share over the previous decade, the Federal Reserve Bank of St. Louis said on Nov. 16.
The federal government's share fell to about 4% from about 11% in 2011, the authors found in “The Changing Face of U.S. Corporate R&D Investment,” published in the bank's On the Economy series.
Hannah Rubinton, a senior economic policy advisor at the bank, and Bontu Ankit Patro, a research associate there, examined company spending from 2011 through 2023.
They used the National Center for Science and Engineering Statistics' Business Enterprise Research and Development Survey, which underpins the Bureau of Economic Analysis' research investment figures. They began in 2011 because the survey introduced its latest structure that year.
Research and development rose from just under 15% of private nonresidential fixed investment in 2012 to a little over 20% at the latest reading, the authors said. That measure covers business investment in structures, equipment and intellectual property.
Within corporate research spending, software's share climbed from 29% in 2011 to nearly 42% in 2023, after peaking at about 43% in 2021, the authors found.
Biotechnology's share more than doubled to almost 19% from about 9% over the same period, while nanotechnology's share stayed relatively steady, they said.
Artificial intelligence accounted for 9% of corporate research spending in 2023, up from about 3% in 2019, when the survey first collected data on that category, the authors found.
The authors said those categories overlap because companies classify their own spending. Research on artificial intelligence chips, for example, can count toward both artificial intelligence and nanotechnology, so category shares can total more than 100%.
The authors also examined the 10 industries with the largest research budgets in 2023. Together, those industries accounted for about 88% of domestic corporate research spending, their calculations showed.
The information industry devoted more than 86% of its research budget to software and about 20% to artificial intelligence, the authors found. Most other industries examined allocated less than 5% to artificial intelligence.
Chemical companies devoted just under 79% of their research spending to biotechnology, compared with 24% in professional, scientific and technical services and about 12% in food, the authors said.
Nanotechnology accounted for 25% of research spending in computer and electronic products and about 21% in machinery, the authors found. Other industries examined allocated single-digit shares.
The authors said future spending would show whether artificial intelligence research becomes as concentrated in particular industries as software and biotechnology research or spreads more broadly.



